Cisco's profit in line with estimates as web traffic drives demand
Research Triangle Park, N.C. —
Profit excluding some items was 52 cents a share, while revenue rose 6 percent to $12.4 billion, the San Jose, California-based company said in a statement today. Analysts on average had projected profit of 51 cents and sales of $12.4 billion, according to data compiled by Bloomberg.
Cisco is benefiting from growing use of Web video and mobile devices that strain data networks and require the purchase of more routers, switches and servers. Investors were predicting a strong quarter from Cisco because spending by U.S. corporations and other markets have been improving, according to Jayson Noland, an analyst at Robert W. Baird & Co. in San Francisco.
“People were expecting a fiscal fourth-quarter beat,” said Noland, who has an outperform rating on the stock, the equivalent of a buy. “If there’s something wrong somewhere in Cisco, given how well things have been going, investors would expect Cisco to make up the difference somewhere else.”
Cisco fell in extended trading. The shares advanced less than 1 percent to $26.38 the close in New York, leaving them up 34 percent this year.
Net income rose 18 percent to $2.27 billion, or 42 cents a share, from $1.92 billion, or 36 cents, a year earlier.
After stumbling amid competition from Hewlett-Packard Co., Juniper Networks Inc. and China’s Huawei Technologies Co., Cisco has regained its footing with new products and increased spending by companies and some government agencies, according to Jayson Noland, an analyst at Robert W. Baird & Co. in San Francisco.
“They went through a lot -- it kind of spiraled out of control there for a little bit but they have come back with a lot of strength,” said Noland, who has an outperform rating on the stock, the equivalent of a buy.
Please Log In to add a comment.
Best of TechWire Insider
- Star Trek gets real: Durham startup delivers interactive holograms
- Every tech company needs to join 'Global Government Surveillance Reform' movement
- Durham entrepreneurs find ally in Charlotte medtech incubator
- GoGown deal shows power, necessity of networking for startups
- New GSK oncology consortium targets combination therapies
- Fighting hospital infections: A Durham nurse's dream produces the GoGown
- From photos to out-of-this-world art: Raleigh firm's software transforms images
- LabCorp expands gene tests for cancer - but don't confuse these with 23andMe
- ChannelAdvisor: Mobile cuts deeply into PC share of online shopping
- Inside Appia's latest funding deal: Debt beats dilution